DESC^Proportion and Incidence Rates for Treatment-Emergent Hypoglycemia (All Causalities) - Long-Term Dose-Controlled Pool 2024
RPTTYPE^ADAE
TABNO^Table LTDCP2024_289a.14.3.1.1
RPTGRAPH^NO
KANJI^NO
APPDX^
SECT^
ITEM^
TABNUM^LTDCP2024_289a.14.3.1.1
PAGESTYL^LANDSCAPE
SOURCEDA^ADTTEAE
INPUTDA^ADTTEAE
G_ADSL_DSIN^DATVPROT.ADSL
G_ADSL_SUBSET^SAFFL EQ 'Y'
G_A_DPTVAR^AVAL
G_A_DSIN^DATVPROT.ADTTEAE
G_A_SLABEL^
G_A_STAT^
G_A_SUBSET^
G_D_BYHEAD^Events
G_D_BYLENGTHS^60
G_D_ODS_ROWJUST^just=left asis=off
G_D_ODS_STATJUST^
G_D_PAGEBYN^0
G_D_ROWHEAD^
G_D_ROWLENGTH^120
G_D_STATHEAD^BLANK
G_D_STATLENGTH^70
G_FMTGEN^
G_R_TPMAX^
G_S_BYVAR^paramn param
G_S_NDISPYN^N
G_S_NSUBGRPDISPYN^
G_S_SUBGRPLABEL^ 
G_S_SUBGRPTOTLABEL^
G_S_SUBGRPTOTYN^
G_S_SUBGRPVAR^ 
G_S_TOTALYN^
G_S_TOTLABEL^
G_S_TRTTXT^TRTA
G_S_TRTVAR^TRTAN
G_TREATMAPGEN^1:Abrocitinib|100mg QD\2:Abrocitinib|200mg QD\1+2:All|Abrocitinib
SUBGROUP^temp
_MLOGIC^Y
_MPRINT^Y
_SYMBOLGEN^Y
TITLE1^&tabno
TITLE2^&protx
TITLE3^&desc
TITLE4^ 
TITLE5^ 
TITLE6^ 
TITLE7^ 
TITLE8^
TITLE9^
TITLE10^
FOOT1^&pspf
FOOT2^&newft
FOOT3^&riskp.
FOOT4^&py.
FOOT5^&abbrhr.
FOOT6^&ci.  
FOOT7^
FOOT8^
FOOT9^
DRVRNAME^adae_hr_all.sasdrvr
DEPEND^$(DATVPROT)adtteae.$(SSD01) $(DATVPROT)adttelb.$(SSD01)
REPREV^$Revision: 1.7 $ $Date: 2025/06/06 08:19:22 $
